Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Bulletin Du Cancer
|
June 30, 2024
Évolution de la prise en charge du cancer du rein : place des biomarqueurs et facteurs pronostiques
Yann-Alexandre Vano
Bulletin Du Cancer
|
September 20, 2021
[New EMA approval: Nivolumab plus Cabozantinib for advanced renal clear cell carcinoma]
Natacha Naoun, Yann-Alexandre Vano
Bulletin Du Cancer
|
January 1, 2019
Yann-Alexandre Vano, Audrey Simonaggio, Constance Thibault, et al.
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice
Jozefina Casuscelli, Yann-Alexandre Vano, Wolf Herve Fridman, et al.
World Journal of Urology
|
January 2, 2021
Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinoma
Ivan Pourmir, Johanna Noel, Audrey Simonaggio, et al.
Cancers
|
February 11, 2021
Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest Developments
Adrien Procureur, Audrey Simonaggio, Jean-Emmanuel Bibault, et al.
International Journal of Molecular Sciences
|
July 27, 2022
MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights
Audrey Simonaggio, Damien Ambrosetti, Virginie Verkarre, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
May 18, 2022
Resistance to cancer immunotherapy in metastatic renal cell carcinoma
Marco Moreira, Cedric Pobel, Nicolas Epaillard, et al.
Cancers
|
January 13, 2021
Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)
Audrey Simonaggio, Nicolas Epaillard, Cédric Pobel, et al.
Current Opinion in Immunology
|
March 20, 2018
Immune-based identification of cancer patients at high risk of progression
Yann-Alexandre Vano, Florent Petitprez, Nicolas A Giraldo, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Bulletin Du Cancer
|
June 30, 2024
Évolution de la prise en charge du cancer du rein : place des biomarqueurs et facteurs pronostiques
Yann-Alexandre Vano
Bulletin Du Cancer
|
September 20, 2021
[New EMA approval: Nivolumab plus Cabozantinib for advanced renal clear cell carcinoma]
Natacha Naoun, Yann-Alexandre Vano
Bulletin Du Cancer
|
January 1, 2019
Yann-Alexandre Vano, Audrey Simonaggio, Constance Thibault, et al.
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice
Jozefina Casuscelli, Yann-Alexandre Vano, Wolf Herve Fridman, et al.
World Journal of Urology
|
January 2, 2021
Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinoma
Ivan Pourmir, Johanna Noel, Audrey Simonaggio, et al.
Cancers
|
February 11, 2021
Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest Developments
Adrien Procureur, Audrey Simonaggio, Jean-Emmanuel Bibault, et al.
International Journal of Molecular Sciences
|
July 27, 2022
MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights
Audrey Simonaggio, Damien Ambrosetti, Virginie Verkarre, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
May 18, 2022
Resistance to cancer immunotherapy in metastatic renal cell carcinoma
Marco Moreira, Cedric Pobel, Nicolas Epaillard, et al.
Cancers
|
January 13, 2021
Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)
Audrey Simonaggio, Nicolas Epaillard, Cédric Pobel, et al.
Current Opinion in Immunology
|
March 20, 2018
Immune-based identification of cancer patients at high risk of progression
Yann-Alexandre Vano, Florent Petitprez, Nicolas A Giraldo, et al.
Page
of 5